Agile Therapeutics, Inc. (AGRX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 3.33M |
| Enterprise Value | 3.24M |
| Trailing P/E | 0.01 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.11 |
| Price/Book (mrq) | 1.78 |
| Enterprise Value/Revenue | 0.20 |
| Enterprise Value/EBITDA | -0.20 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.13 |
| 52-Week Change 3 | -87.82% |
| S&P500 52-Week Change 3 | 18.47% |
| 52 Week High 3 | 16.0000 |
| 52 Week Low 3 | 1.6500 |
| 50-Day Moving Average 3 | 2.4185 |
| 200-Day Moving Average 3 | 7.2626 |
Share Statistics
| Avg Vol (3 month) 3 | 48.9k |
| Avg Vol (10 day) 3 | 41.38k |
| Shares Outstanding 5 | 1.93M |
| Implied Shares Outstanding 6 | 1.93M |
| Float 8 | 1.8M |
| % Held by Insiders 1 | 3.41% |
| % Held by Institutions 1 | 1.04% |
| Shares Short (Aug 30, 2023) 4 | 10.65k |
| Short Ratio (Aug 30, 2023) 4 | 0.24 |
| Short % of Float (Aug 30, 2023) 4 | 0.55% |
| Short % of Shares Outstanding (Aug 30, 2023) 4 | 0.55% |
| Shares Short (prior month Jul 30, 2023) 4 | 38.48k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:50 |
| Last Split Date 3 | Apr 10, 2023 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2022 |
| Most Recent Quarter (mrq) | Jun 29, 2023 |
Profitability
| Profit Margin | -116.82% |
| Operating Margin (ttm) | -161.20% |
Management Effectiveness
| Return on Assets (ttm) | -72.40% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 16.31M |
| Revenue Per Share (ttm) | 15.31 |
| Quarterly Revenue Growth (yoy) | 158.80% |
| Gross Profit (ttm) | N/A |
| EBITDA | -25.75M |
| Net Income Avi to Common (ttm) | -19.06M |
| Diluted EPS (ttm) | 126.9100 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.79M |
| Total Cash Per Share (mrq) | 1.45 |
| Total Debt (mrq) | 2.69M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.76 |
| Book Value Per Share (mrq) | -7.39 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -28.38M |
| Levered Free Cash Flow (ttm) | -19.91M |
© 2023 Yahoo. All rights reserved.
